Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Breast Neoplasms 14Prostatic Neoplasms 3Neoplasms, Hormone-Dependent 3Carcinoma, Lobular 3Carcinoma, Ductal, Breast 3Prostatic Intraepithelial Neoplasia 2Fractures, Bone 2Desmoid Tumors 2Triple Negative Breast Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Osteoporosis 1Neoplasms 1Carcinoma, Ovarian Epithelial 1Breast Carcinoma In Situ 1Breast Cancer Patients in Premenopausal 1Bone Diseases, Metabolic 1

Interventions

nirogacestat 6Specimen Handling 3Nivolumab 3Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3X-Rays 2Toremifene 2Phantoms, Imaging 2Cryosurgery 2Blood Specimen Collection 2vactosertib 1trifluridine tipiracil drug combination 1strattice 1liposomal doxorubicin 1entinostat 1anlotinib 1Vinblastine 1Taxes 1Tamoxifen 1Sunitinib 1Sulindac 1Sorafenib 1Sirolimus 1Saline Solution 1Radiotherapy 1Radiofrequency Ablation 1Oxaliplatin 1Methotrexate 1Leucovorin 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Desmoid Tumors × Toremifene × Clear all
NCT02353429 2015-02-02

Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
25 enrolled
Sarcoma

Desmoid Tumors

NCT00002595 2013-07-10

Toremifene in Treating Patients With Desmoid Tumors

National Cancer Institute (NCI)

Phase 2 Completed
72 enrolled
Sarcoma

Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡